<!doctype html><html lang="en"><head><meta name="generator" content="Scully 0.0.0"><meta charset="utf-8"><title>Research | Zoldos Group</title><base href="/"><meta name="viewport" content="width=device-width,initial-scale=1"><link rel="icon" type="image/x-icon" href="favicon.ico"><link rel="manifest" href="manifest.webmanifest"><meta name="theme-color" content="#1976d2"><link rel="stylesheet" href="styles.300e1a536fed1c171fa2.css"><style></style><meta name="description" content="This is our research"><meta name="keywords" content="research"><style>.header[_ngcontent-dhu-c9]{padding:10px;flex-wrap:wrap;height:65px;justify-content:space-between}.header-links[_ngcontent-dhu-c9],.header[_ngcontent-dhu-c9]{display:flex;align-items:center}.header-links[_ngcontent-dhu-c9]{justify-content:flex-end;width:70%;z-index:40}.header-logo[_ngcontent-dhu-c9]{width:30%;text-align:left;z-index:40}.links[_ngcontent-dhu-c9]{margin:0 10px}.logo[_ngcontent-dhu-c9]{font-size:35px}</style><style>.research-post[_ngcontent-dhu-c15]{flex-wrap:wrap;justify-content:center;max-width:1400px;width:100%;margin:0 auto}.specifications[_ngcontent-dhu-c15]{background:linear-gradient(90deg,#74ebd5,#acb6e5);text-align:center}h1[_ngcontent-dhu-c15],h2[_ngcontent-dhu-c15],h3[_ngcontent-dhu-c15],h4[_ngcontent-dhu-c15],p[_ngcontent-dhu-c15]{font-family:helvetica}.card[_ngcontent-dhu-c15]{align-content:center;box-shadow:8px 4px 8px 4px rgba(0,0,0,.2);transition:.3s}.card[_ngcontent-dhu-c15]:hover{box-shadow:16px 8px 16px 8px rgba(0,0,0,.2)}.container[_ngcontent-dhu-c15],.image-cropper[_ngcontent-dhu-c15]{align-content:center}.image-cropper[_ngcontent-dhu-c15]{max-width:100px;height:auto;position:relative;overflow:hidden}.lab-member-card[_ngcontent-dhu-c15]{box-shadow:0 4px 8px 0 rgba(0,0,0,.2);max-width:300px;margin:auto;text-align:center}.title[_ngcontent-dhu-c15]{color:grey}.title[_ngcontent-dhu-c15],button[_ngcontent-dhu-c15]{font-size:18px}button[_ngcontent-dhu-c15]{border:none;outline:0;display:inline-block;padding:8px;color:#fff;background-color:#000;text-align:center;cursor:pointer;width:100%}a[_ngcontent-dhu-c15]{text-decoration:none;font-size:22px;color:#000}a[_ngcontent-dhu-c15]:hover,button[_ngcontent-dhu-c15]:hover{opacity:.7}.lab-members[_ngcontent-dhu-c15],.research-section[_ngcontent-dhu-c15]{display:flex}.research-image-block-wrapper[_ngcontent-dhu-c15]{width:50%;display:flex;flex-wrap:wrap;justify-content:space-between;padding:20px}.research-image-block-text[_ngcontent-dhu-c15]{font-family:Raleway,Arial,Helvetica,sans-serif;width:65%;text-align:right}.research-image-block-left[_ngcontent-dhu-c15]{font-family:Raleway,Arial,Helvetica,sans-serif;width:60%;text-align:left}.research-image-block-title[_ngcontent-dhu-c15]{color:#484848!important;font-weight:700;text-transform:uppercase}.research-image-block-subtitle[_ngcontent-dhu-c15]{font-size:1.7em;color:#aaa}.research-image-block-name[_ngcontent-dhu-c15]{text-transform:uppercase;font-size:.9em;color:#aaa}.research-image-block-content[_ngcontent-dhu-c15]{color:#666;font-size:15px}.research-image-block-image[_ngcontent-dhu-c15]{width:30%;display:flex;align-items:center;justify-content:center}.research-image-block-bg[_ngcontent-dhu-c15]{height:200px;background-repeat:no-repeat;background-size:cover;background-position:50%;width:100%;border:9px solid #868686;border-radius:50%}.even[_ngcontent-dhu-c15]{flex-direction:row-reverse;text-align:left}</style><script>window.ScullyIO="generated"</script></head><body scully-version="0.0.0"><zg-root _nghost-dhu-c20="" ng-version="9.1.1"><router-outlet _ngcontent-dhu-c20=""></router-outlet><zg-layout _nghost-dhu-c9=""><header _ngcontent-dhu-c9=""><div _ngcontent-dhu-c9="" class="header"><div _ngcontent-dhu-c9="" class="header-logo"><a _ngcontent-dhu-c9="" routerlink="/" routerlinkactive="" class="logo" href="/">Logo</a></div><div _ngcontent-dhu-c9="" class="header-links"><a _ngcontent-dhu-c9="" routerlinkactive="active" class="links active" href="/">Home</a><a _ngcontent-dhu-c9="" routerlinkactive="active" class="links" href="/researches/">Researches</a><a _ngcontent-dhu-c9="" routerlinkactive="active" class="links" href="/lab-members/">Lab Members</a><a _ngcontent-dhu-c9="" routerlinkactive="active" class="links" href="/publications/">Publications</a><a _ngcontent-dhu-c9="" routerlinkactive="active" class="links" href="/news/">News</a><a _ngcontent-dhu-c9="" routerlinkactive="active" class="links" href="/other-info">Other Information</a><a _ngcontent-dhu-c9="" routerlinkactive="active" class="links" href="/photo-gallery/">Photo Gallery</a><a _ngcontent-dhu-c9="" routerlinkactive="active" class="links" href="/contact/">Contact</a></div></div></header><router-outlet _ngcontent-dhu-c9=""></router-outlet><zg-page _nghost-dhu-c19=""><zg-block-renderer _ngcontent-dhu-c19="" _nghost-dhu-c18=""></zg-block-renderer><zg-test-block _nghost-dhu-c15=""><div _ngcontent-dhu-c15=""><h1 _ngcontent-dhu-c15="" class="m-a-s">RESEARCH</h1><h3 _ngcontent-dhu-c15="" class="m-a-s">Here you can read all of our research</h3></div><section _ngcontent-dhu-c15="" class="research-image-block m-y-xl"><div _ngcontent-dhu-c15="" class="grid jc-start"><div _ngcontent-dhu-c15="" class="col-12 ta-center m-y-l"><h2 _ngcontent-dhu-c15="" class="research-image-block-title">Research 1</h2><p _ngcontent-dhu-c15="" class="research-image-block-subtitle">Vlatka Zoldoš</p></div><div _ngcontent-dhu-c15="" class="research-image-block-wrapper m-b-l"><div _ngcontent-dhu-c15="" class="research-image-block-text"><h5 _ngcontent-dhu-c15="" class="research-image-block-title">A Systems medicine approach to chronic inflammatory disease</h5><p _ngcontent-dhu-c15="" class="research-image-block-name m-y-s">Zoldoš group is involved in SYSCID project within the Workpackage WP9 (led by HUNIMED) by epigenetic reprogamming to cis-regulatory regions (i.e. pathogenic variants associated to CID, previously identified by partner Humanitas University, Milan, Italy) using dCas9 fusions (with activator and repressor domains, and/or epigenetic reader/eraser domains).</p><p _ngcontent-dhu-c15="" class="research-image-block-content">The main goal is to model the impact of the most relevant pathogenic nucleotide variants on the gene expression programs of myeloid cells and CD8 cells.</p></div><div _ngcontent-dhu-c15="" class="research-image-block-image br-circle"><div _ngcontent-dhu-c15="" class="research-image-block-bg"><img _ngcontent-dhu-c15="" src="assets/icons/flask.svg"></div></div></div></div></section><section _ngcontent-dhu-c15="" class="research-post"><h2 _ngcontent-dhu-c15="" class="m-a-l col-12 ta-center">A Systems medicine approach to chronic inflammatory disease</h2><img _ngcontent-dhu-c15="" src="/assets/images/landing.png"><p _ngcontent-dhu-c15="">A SYSCID consortium aims to develop a system medicine approach for disease prediction in chronic inflammatory diseases (CID). We will focus on three major CID indications with distinct characteristics, yet a large overlap of their molecular risk map: inflammatory bowel disease. systemic lupus erythematosus and rheumatoid arthritis. There are 15 partners from major cohorts and initiatives in Europe joined in this project (i.e. IHEC, ICGC, Twins UK and Meta-HIT) to investigate human dana sets on three major levels of resolution: whole blood signatures, signatures from purified immune cell types (with focus on CD14 and CD4/CD8) and selected single cell analyses. Principle data layers will comprise SNPs, methylome, transcriptome and gut microbiome. Using this set up we will focus on three fundamental aims: (i) the identification of shared and unique «core disease signatures, which are associated with the disease state and independent of temporal variation, (ii) the generation of «predictive models of disease outcome» – builds on previous work that pathways/biomarkers for disease outcome and distinct from initial disease risk may be shared across disease to guide therapy decisions on an individual patient basis, (iii) «reprogramming disease» – will identify and target temporarily stable epigenetic alterations in macrophages and lymphocytes in epigenome editing approaches as biological validation and potential novel therapeutic tools.</p><p _ngcontent-dhu-c15="" class="m-y-m"><b _ngcontent-dhu-c15="">Zoldoš group</b> is involved in SYSCID project within the Workpackage WP9 (led by HUNIMED) by epigenetic reprogamming to cis-regulatory regions (i.e. pathogenic variants associated to CID, previously identified by partner Humanitas University, Milan, Italy) using dCas9 fusions (with activator and repressor domains, and/or epigenetic reader/eraser domains). The main goal is to model the impact of the most relevant pathogenic nucleotide variants on the gene expression programs of myeloid cells and CD8 cells. We will infer the possible functional impact of corrective interventions selectively targeting the activity of the regulatory elements harbouring such variants. Using multiple targeting and orthogonal regulation (simultaneous activation and repression of genes in the same cell) will aim to enable precise pathway shaping.</p><div _ngcontent-dhu-c15="" class="specifications"><p _ngcontent-dhu-c15=""><b _ngcontent-dhu-c15="">Type of funding scheme:</b> RIA; Coordination and support action; Support actions</p><p _ngcontent-dhu-c15="" class="m-y-s"><b _ngcontent-dhu-c15="">Work programme topics:</b> HEALTH Innovative and personalized medicine</p><p _ngcontent-dhu-c15=""><b _ngcontent-dhu-c15="">EU FP7 Call:</b> H2020-SCI1-2016-RTD</p><p _ngcontent-dhu-c15="" class="m-y-s"><b _ngcontent-dhu-c15="">Proposal number:</b> 733100</p><p _ngcontent-dhu-c15=""><b _ngcontent-dhu-c15="">Duration:</b> 60 months (1st January 2017 – 31st March 2022)</p><p _ngcontent-dhu-c15="" class="m-y-s"><b _ngcontent-dhu-c15="">Host institution:</b> Genos (third party Faculty of Science University of Zagreb)</p><p _ngcontent-dhu-c15=""><b _ngcontent-dhu-c15="">Coordinating person:</b> Professor Philip Rosenstiel, PhD, Christian-Albrechts-University Kiel with University Hospital Schleswig Holstein, Campus Kiel</p><p _ngcontent-dhu-c15="" class="m-y-s"><b _ngcontent-dhu-c15="">EU Funding to Genos and Faculty of Science:</b> 880,000.00 Eur</p><p _ngcontent-dhu-c15=""><b _ngcontent-dhu-c15="">Detailed information:</b> http://syscid.eu/home/</p></div></section><div _ngcontent-dhu-c15=""><h1 _ngcontent-dhu-c15="" class="m-a-s">LAB MEMBERS</h1><h3 _ngcontent-dhu-c15="" class="m-a-s">Meet our lab members</h3></div><section _ngcontent-dhu-c15="" class="lab-members"><div _ngcontent-dhu-c15="" class="lab-member-card"><img _ngcontent-dhu-c15="" src="/assets/images/landing.png" alt="Vlatka Zoldoš" style="width:100%"><h1 _ngcontent-dhu-c15="">Vlatka Zoldoš</h1><p _ngcontent-dhu-c15="" class="title">CEO &amp; Founder</p><p _ngcontent-dhu-c15="">Faculty of Science University of Zagreb</p><a _ngcontent-dhu-c15="" href="#"><i _ngcontent-dhu-c15="" class="fa fa-twitter"></i></a><a _ngcontent-dhu-c15="" href="#"><i _ngcontent-dhu-c15="" class="fa fa-linkedin"></i></a><a _ngcontent-dhu-c15="" href="#"><i _ngcontent-dhu-c15="" class="fa fa-facebook"></i></a><p _ngcontent-dhu-c15=""><button _ngcontent-dhu-c15="">Read More</button></p></div><div _ngcontent-dhu-c15="" class="lab-member-card"><img _ngcontent-dhu-c15="" src="/assets/images/landing.png" alt="Aleksandar Vojta" style="width:100%"><h1 _ngcontent-dhu-c15="">Aleksandar Vojta</h1><p _ngcontent-dhu-c15="" class="title">Assistant Professor</p><p _ngcontent-dhu-c15="">Faculty of Science University of Zagreb</p><a _ngcontent-dhu-c15="" href="#"><i _ngcontent-dhu-c15="" class="fa fa-twitter"></i></a><a _ngcontent-dhu-c15="" href="#"><i _ngcontent-dhu-c15="" class="fa fa-linkedin"></i></a><a _ngcontent-dhu-c15="" href="#"><i _ngcontent-dhu-c15="" class="fa fa-facebook"></i></a><p _ngcontent-dhu-c15=""><button _ngcontent-dhu-c15="">Read More</button></p></div></section><div _ngcontent-dhu-c15="" class="lab-member-bio m-a-l"><h1 _ngcontent-dhu-c15="">Vlatka Zoldoš</h1><p _ngcontent-dhu-c15="">Vlatka Zoldoš, PhD, is a full professor at the University of Zagreb Faculty of Science, and a principle investigator running a Laboratory for epigenetics at the Department of molecular biology. She completed her PhD at the University of Paris Sud XI in France in 2000 as a scholar of French government. She moved back to Croatia where she was elected as an assistant professor at the University of Zagreb Faculty of science in 2003. Her main research interest is epigenetics of protein glycosylation associated with human diseases. Her pioneering efforts in this field resulted in several prominent papers including the first demonstration of the epigenetic regulation of plasma protein and IgG glycosylation. She and her team were the first who have developed CRISPR/dCas9-based molecular tools for targeted DNA methylation/demethylation. She is involved in several large projects funded by EU foundations, and her group is a part of the Centre of Scientific Excellence in Personalized Healthcare and Centre of Competence in Molecular Diagnostics in Croatia. She is teaching Genetics, Epigenetics and Molecular Cytogenetics for students of undergraduate and graduate studies of Master’s degree in Molecular Biology at the Faculty of Science and doctorate study of Biology at the University of Zagreb.<br _ngcontent-dhu-c15=""><b _ngcontent-dhu-c15="">vzoldos@zg.biol.pmf.hr</b></p></div><div _ngcontent-dhu-c15="" class="lab-member-bio m-a-l"><h1 _ngcontent-dhu-c15="">Aleksandar Vojta</h1><p _ngcontent-dhu-c15="">Aleksandar Vojta obtained his Ph.D. (dr. rer. nat.) in 2006 from Ludwig-Maximilians-Universität in Munich, Germany, in the field of cell biology, with a focus on protein import into chloroplasts. He came back to Croatia and was working from 2007 to 2012 at the Faculty of Veterinary Medicine, University of Zagreb, where he obtained his second Ph.D. in Veterinary sciences. He joined Zoldoš Lab in 2012 working as a senior researcher on Horizon2020 Regional Potential Project Integra-Life. In 2015, he was appointed assistant professor at the University of Zagreb, Faculty of Science, where he teaches courses in Cell biology, Genetic engineering, Genetics and Population genetics for undergraduate and graduate students of Master’s degree in Molecular Biology. His main research focus is a design of molecular tools for epigenome editing and gene regulation based on CRISPR/Cas9 technology and development of a transient system HEK293FreeStyle for IgG production.<br _ngcontent-dhu-c15=""><b _ngcontent-dhu-c15="">vojta@biol.pmf.hr</b></p></div></zg-test-block></zg-page><footer _ngcontent-dhu-c9=""></footer></zg-layout></zg-root><noscript>Please enable JavaScript to continue using this application.</noscript><script src="runtime-es2015.479d21a31fe1cc16e4c9.js" type="module"></script><script src="runtime-es5.479d21a31fe1cc16e4c9.js" nomodule="" defer></script><script src="polyfills-es5.c6a0ae5254236685dfe3.js" nomodule="" defer></script><script src="polyfills-es2015.d83b230669affd1c9acc.js" type="module"></script><script src="main-es2015.f5dd6f6e4f33666ab2d1.js" type="module"></script><script src="main-es5.f5dd6f6e4f33666ab2d1.js" nomodule="" defer></script></body></html>